Vineet Laboratories DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	1.34×	1.25×	0.97×	2.83×	0.62×
	0.37×	0.21×	1.11×	0.08×	0.38×
	12.9%	10.2%	−25.0%	3.1%	2.5%
	0.54×	0.54×	0.71×	1.29×	1.83×
	2.74×	2.74×	6.45×	3.37×	3.44×
	9.4%	4.0%	−123.4%	3.0%	3.7%
	5.3%	5.3%	−81.8%	3.0%	3.7%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

VINEETLAB₹37.76

Vineet Laboratories Limited

· Pharma & Health

₹ CrorePeersBIOFILCHEM MANGALAM LASA KREBSBIO ALPA BALPHARMA ORTINGLOBE NATCAPSUQMcap ₹72.5 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.62	2.83	0.97	1.25	1.34
Interest Burden (Pretax/EBIT) ×	0.38	0.08	1.11	0.21	0.37
EBIT Margin %	2.49	3.11	-25.05	10.21	12.86
Asset Turnover ×	1.83	1.29	0.71	0.54	0.54
Financial Leverage (Assets/Equity) ×	3.44	3.37	6.45	2.74	2.74
ROE (5-step product, year-end total equity) %	3.71	2.96	-123.38	3.99	9.44
ROE (owners' profit / average owners' equity) %	3.72	3.00	-81.79	5.32	5.32

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.